Jeffrey Hausdorff to Doxorubicin
This is a "connection" page, showing publications Jeffrey Hausdorff has written about Doxorubicin.
Connection Strength
0.048
-
Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy. Cancer J Sci Am. 1997 Sep-Oct; 3(5):303-11.
Score: 0.036
-
A phase I trial of doxorubicin, paclitaxel, and valspodar (PSC 833), a modulator of multidrug resistance. Clin Cancer Res. 2001 May; 7(5):1221-9.
Score: 0.012